- Home
- ABUS vs UFCS Comparison
ABUS vs UFCS Comparison
Compare ABUS & UFCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABUS
- UFCS
- Stock Information
- Founded
- ABUS N/A
- UFCS 1946
- Country
- ABUS United States
- UFCS United States
- Employees
- ABUS N/A
- UFCS N/A
- Industry
- ABUS Biotechnology: Pharmaceutical Preparations
- UFCS Property-Casualty Insurers
- Sector
- ABUS Health Care
- UFCS Finance
- Exchange
- ABUS Nasdaq
- UFCS Nasdaq
- Market Cap
- ABUS 629.1M
- UFCS 679.4M
- IPO Year
- ABUS N/A
- UFCS N/A
- Fundamental
- Price
- ABUS $3.42
- UFCS $25.47
- Analyst Decision
- ABUS Strong Buy
- UFCS Hold
- Analyst Count
- ABUS 4
- UFCS 1
- Target Price
- ABUS $5.50
- UFCS $28.00
- AVG Volume (30 Days)
- ABUS 646.4K
- UFCS 156.6K
- Earning Date
- ABUS 03-03-2025
- UFCS 02-11-2025
- Dividend Yield
- ABUS N/A
- UFCS 2.51%
- EPS Growth
- ABUS N/A
- UFCS N/A
- EPS
- ABUS N/A
- UFCS 2.39
- Revenue
- ABUS $6,742,000.00
- UFCS $1,253,307,000.00
- Revenue This Year
- ABUS N/A
- UFCS N/A
- Revenue Next Year
- ABUS N/A
- UFCS $9.59
- P/E Ratio
- ABUS N/A
- UFCS $10.66
- Revenue Growth
- ABUS N/A
- UFCS 14.41
- 52 Week Low
- ABUS $2.30
- UFCS $18.04
- 52 Week High
- ABUS $4.72
- UFCS $31.70
- Technical
- Relative Strength Index (RSI)
- ABUS 54.07
- UFCS 44.80
- Support Level
- ABUS $3.24
- UFCS $24.57
- Resistance Level
- ABUS $3.44
- UFCS $27.54
- Average True Range (ATR)
- ABUS 0.12
- UFCS 0.96
- MACD
- ABUS 0.01
- UFCS 0.17
- Stochastic Oscillator
- ABUS 55.56
- UFCS 32.23
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.
About UFCS United Fire Group Inc.
United Fire Group Inc is engaged in the business of writing property and casualty insurance and selling annuities through a network of independent agencies. The company's only operating segment is property and casualty insurance, which includes commercial lines insurance, personal lines insurance, and assumed reinsurance. The primary source of revenue is premium and investment income.